Dihexa Reconstitution

Dihexa does not reconstitute the way a peptide does, and treating it like one is the most common handling error associated with it. It is small, heavily modified and markedly lipophilic — properties that make water a poor solvent and that change the procedure substantially.

Proxiva Catalogue DeskFormats, presentations and per-milligram economics

Why water does not work well here

Solubility is not a matter of effort. A compound dissolves in a solvent when the interactions it can form with that solvent are favourable compared with the interactions holding the solid together. Where they are not, prolonged agitation produces a suspension rather than a solution.

Most research peptides are reasonably water-soluble because amino-acid backbones present many polar groups — amide bonds, charged side chains, hydroxyls — all of which interact readily with water. That is why standard practice works for BPC-157, Ipamorelin, Semax and the rest of a typical catalogue.

Dihexa is built differently. It descends from a short peptide sequence but carries two substantial hydrophobic modifications, and those dominate its behaviour. The molecule presents far more nonpolar surface than a comparable peptide, and water interacts with nonpolar surface poorly.

The result is a compound in a genuinely different solubility class from almost everything else on a peptide shelf, despite being sold beside them.

What incomplete dissolution looks like

Learn the signs. Miss them and every number downstream is wrong.

Hold the vial to a light. Tilt it slowly. Look at the bottom seam.

• Watch for haze. A faint cloudiness means undissolved material. Do not proceed.
• Watch for film. A translucent smear on the glass is the compound, not a mark.
• Watch for specks. Small particles settle at the seam within a minute of standing.
• Watch for shimmer. Tilt the vial and look for a slick that moves separately.
• Never judge a solution while it is swirling. Let it stand. Then look.

Do not assume clear means dissolved. Thin films do not scatter light. They still represent lost material.

Do not fix haze by shaking. Shaking disperses particles. It does not dissolve them. The haze clears and the problem stays.

Do not add more diluent to force it. You have now changed the concentration without knowing the numerator.

Understand what this costs. Undissolved compound is compound you paid for and cannot draw. Your stated concentration is too high. Every calculation from it is wrong, and wrong in the direction that looks like the compound underperforming.

Check before the first withdrawal. Not after.

How compounds in this class are handled

The standard approach for a poorly water-soluble research compound is a co-solvent: dissolve first in a solvent the compound actually favours, then dilute into the aqueous carrier.

Dimethyl sulfoxide is the usual first choice because it dissolves a very wide range of organic compounds and is miscible with water. The compound goes into a small volume of DMSO, and that concentrate is then diluted into the aqueous medium.

Two constraints govern this and both are worth knowing before starting:

• Final DMSO concentration matters. The solvent is not inert in biological systems, so protocols generally hold it well below the point where it becomes a variable in its own right.
• Dilution can precipitate the compound back out. Adding the concentrate too quickly to aqueous medium creates a local region where the compound is past its solubility limit, and it crashes out. Adding slowly, with the receiving solution in motion, avoids this.

The specific solvent and ratio should come from the supplier's documentation for the batch you hold, not from a general protocol. This is exactly the situation where a supplier that publishes real handling guidance distinguishes itself from one that supplies a template.

Working out concentration when a co-solvent is involved

Concentration arithmetic gets a step more complicated once two solvents are in play, and getting it wrong is a quiet source of irreproducible work.

With a single solvent the calculation is trivial: mass divided by volume. With a co-solvent system there are two numbers to track — the concentration of the stock in DMSO, and the concentration after dilution into the aqueous carrier. Confusing them is easy and the error is invisible afterwards.

The sequence that avoids it:

• Dissolve the full vial contents in a measured volume of DMSO. That gives the stock concentration — record it.
• Decide the final working concentration the protocol needs.
• Calculate the dilution factor between the two, and check that the resulting DMSO fraction stays inside whatever limit the assay tolerates.
• Add the stock to the aqueous carrier slowly, with the carrier in motion — not the reverse. Adding water to a concentrated organic stock is the classic way to precipitate the compound.

That last point is worth emphasising because it runs against instinct. The direction of addition matters: introducing a small volume of concentrated stock into a large volume of moving aqueous medium keeps the compound below its solubility limit at every moment. Doing it the other way creates a concentrated pocket that crashes out immediately, and once precipitated it does not readily redissolve.

Both numbers belong on the label, along with the date and the solvent system. A vial marked only with a concentration is ambiguous about which concentration it means, and that ambiguity is unrecoverable a week later.

Where standard peptide practice still applies

Everything downstream of the solvent choice is unchanged, and the reasoning behind each step is the same as for any research compound.

• Bring the vial to room temperature before opening, so moisture does not condense onto cold material
• Swab the stopper with alcohol and let it dry before every draw, not only the first
• Add solvent slowly down the vial wall rather than directly onto the solid
• Swirl or roll to dissolve; never shake
• Label immediately with the date, the solvent used and the final concentration
• Refrigerate, protect from light, and never re-freeze a prepared solution

The labelling step carries extra weight here because the solvent system is part of the record. A vial labelled only with a date and concentration is missing the information that makes the preparation reproducible.

General procedure and the reasoning behind each rule is in reconstituting research peptides, and stability considerations in peptide storage and stability. Bacteriostatic water remains the right aqueous carrier for multi-draw work in either case, since the benzyl alcohol suppresses microbial growth across repeated punctures.

Verification for a modified small molecule

Dihexa is documented like a small molecule rather than like a peptide, and certificates that miss this are common.

HPLC works normally and reports purity as a proportion of UV-absorbing material. Mass spectrometry applies too, but identity is confirmed against a molecular formula rather than a mass calculated from an amino-acid sequence — there is no plain sequence to calculate from once the modifications are present.

NMR is more often available for small molecules than for peptides, and where a supplier provides it, it is stronger evidence than mass alone because it reports on structure rather than only on weight.

• HPLC purity with the chromatogram image included
• Identity by mass spectrometry against the correct modified mass, or ideally NMR
• Batch number matching the vial label exactly
• Named testing laboratory, independent of synthesis
• Residual solvents appropriate to the synthesis route
• Solubility guidance — for a compound in this class its absence is itself a finding
• Salt form, where applicable, since a counterion contributes to stated weight

The tell to watch for: a certificate reporting a "sequence" for a compound whose identity is not a sequence has been produced from a peptide template rather than from analysis. Field-by-field detail in how to read a certificate of analysis.

Related compounds and sourcing

Researchers who encounter dihexa are usually working on cognitive or neurotrophic questions, and the compounds most often held alongside it in that area are conventional peptides with conventional handling.

Semax and Selank are the common pair, both water-soluble and both following standard reconstitution — compared in our Semax versus Selank comparison, along with the caveat that much of their primary literature is Russian-language and hard to evaluate. They are also available together as a combined vial.

DSIP appears in adjacent sleep-related research, and 5-Amino-1MQ is another non-peptide sold on peptide shelves — worth reading for the same documentation reasons, covered in the 5-Amino-1MQ guide. Broader metabolic panels commonly add NAD+, Epithalon, MOTS-c, SS-31 and Glutathione.

For general supplier assessment — including why vendor longevity stopped being a reliable signal during 2026 — see choosing a research peptide supplier. The compounds above are stocked as BPC-157, TB-500, Ipamorelin, GHK-Cu, KPV, PT-141 and Melanotan II among others.

Frequently asked questions

Research use only. All products referenced on this page are sold strictly for laboratory and research purposes. They are not drugs, foods, cosmetics, or medical devices, and they are not intended to diagnose, treat, cure, or prevent any disease. They are not for human or veterinary consumption. Handling should be performed only by qualified individuals in an appropriate laboratory setting.